Boston Partners’s Cambrex Corporation CBM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-256,255
Closed -$9.68M 751
2018
Q4
$9.68M Buy
256,255
+15,399
+6% +$780K 0.01% 376
2018
Q3
$16.5M Sell
240,856
-458,430
-66% -$28.3M 0.02% 340
2018
Q2
$36.6M Buy
699,286
+21,399
+3% +$1.07M 0.04% 280
2018
Q1
$35.5M Sell
677,887
-31,899
-4% -$1.71M 0.04% 281
2017
Q4
$34.1M Buy
709,786
+384,897
+118% +$19.1M 0.04% 278
2017
Q3
$17.9M Buy
+324,889
New +$17.9M 0.02% 325

Other funds holding CBM

Boston Partners's CBM Position: Q1 2019 in Review

Boston Partners sold out of Cambrex Corporation (CBM) in Q1 2019, closing a stake of 256,255 shares — an estimated $9.68M sold.

Boston Partners first reported a position in CBM in Q3 2017 and held it in 6 quarters. The position peaked at $36.6M in Q2 2018. 211 funds tracked by Wall St. Rank hold CBM as of Q1 2019.

  • Boston Partners reported no remaining Cambrex Corporation position as of Q1 2019 after selling out during the quarter.
  • Boston Partners sold 256,255 Cambrex Corporation shares in Q1 2019, an estimated $9.68M.
  • Boston Partners first reported a position in Cambrex Corporation in Q3 2017 and held it in 6 quarters.
  • Boston Partners's Cambrex Corporation position peaked at $36.6M in Q2 2018.
  • 211 funds tracked by Wall St. Rank held Cambrex Corporation as of Q1 2019.

Based on Boston Partners's 13F filing for Q1 2019, filed 3 May 2019.